Study Comparing Cryoablation of Pericapsular Nerve Group PENG Versus Fascia Iliaca Catheter for Pain Relief After Hip Fracture Surgery in Adults 18 to 85

What this Trial Is About

Researchers are evaluating pain control methods after hip fracture surgery in adults aged 18 to 85. This Phase 4 trial compares cryoablation of the Pericapsular Nerve Group PENG with the use of a fascia iliaca catheter to determine which approach offers better pain relief 30 days after surgery. The study is sponsored by the University of Minnesota and focuses on improving recovery outcomes for patients with hip fractures. Participants will be randomly assigned to one of two treatment groups. One group will receive an ultrasound-guided PENG block with 20 mL of 0.5% bupivacaine followed by cryoablation of the PENG nerves. The other group will receive an ultrasound-guided fascia iliaca compartment catheter with an initial bolus of 20 mL of 0.5% bupivacaine and a continuous infusion of 0.2% ropivacaine at 10 mL per hour. Both interventions are delivered after hip fracture repair surgery. During the study, researchers will monitor participants maximum pain scores 30 days after surgery, opioid use on days 0 through 7 post-surgery, functional pain scores during the first week, length of hospital stay, time to first walking, and the number of patients who have returned home by 30 days. The study involves close follow-up over the first month after surgery to assess pain control and recovery progress.

Comparison of Cryoablation of Pericapsular Nerve Group (PENG) to Fascia Iliaca Catheter in Patients With a Hip Fracture